Diseases & Conditions Market Research Reports & Industry Analysis
Insomnia is a common condition in which one has trouble going to sleep or staying asleep. This condition can range from weak to strong, depending on how often it occurs and for how long. Insomnia can be ongoing or acute. Chronic insomnia means having symptoms at least 3 nights a week for more than a month. Acute insomnia lasts for less time. Some people who have insomnia will have trouble falling asleep. Other people may fall asleep easily but, then wake up.
Diseases & Conditions Industry Research & Market Reports
-
Disposable Masks
... CAGR of 6.2% over the analysis period 2024-2030. Surgical Masks, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$19.1 Billion by the end of the analysis ... Read More
-
Industrial Protective Footwear
... at a CAGR of 6.6% over the analysis period 2024-2030. Leather Footwear, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$3.8 Billion by the end of ... Read More
-
Protective Eyewear
... CAGR of 4.6% over the analysis period 2024-2030. Industrial Manufacturing, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.2 Billion by the end of the analysis ... Read More
-
Form Fill and Sealing (FFS) Equipment
... reach US$13.7 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2024-2030. Horizontal FFS Equipment, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and ... Read More
-
Ewing Sarcoma - Market Insight, Epidemiology, and Market Forecast - 2034
... because most Ewing sarcoma Patients are under 20 years old. Although there is no standardized second-line treatment for refractory or relapsed Ewing sarcoma, several retrospective studies have reported on conventional salvage treatments. Chemotherapy and local ... Read More
-
Alzheimer's Disease - Market Insight, Epidemiology, and Market Forecast - 2034
... on healthcare systems and patient care. In 2023, among the EU4 and the UK, Germany accounted for the highest diagnosed prevalent cases of Alzheimer’s disease, representing 30% of the total cases, followed by France (24%). ... Read More
-
Herpes Zoster Treatment
... at a CAGR of 1.9% over the analysis period 2024-2030. Antiviral Medications, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$134.0 Million by the end of ... Read More
-
Cervical Cancer Endoscopic Devices
... 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Optical Colposcopes, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$668.1 Million by the ... Read More
-
Asthma Spacers
... CAGR of 2.6% over the analysis period 2024-2030. Aerochamber Spacer, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$508.7 Million by the end of the analysis ... Read More
-
Immunomodulators
... 5.7% over the analysis period 2024-2030. Immunosuppressants, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$209.8 Million by the end of the analysis period. Growth in ... Read More
-
Insulin Storage Devices
... at a CAGR of 7.5% over the analysis period 2024-2030. Battery Operated Devices, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$996.0 Million by the end ... Read More
-
Osteoarthritis Therapeutics
... CAGR of 7.3% over the analysis period 2024-2030. Knee, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$7.1 Billion by the end of the analysis period. ... Read More
-
Particle Therapy
... CAGR of 8.8% over the analysis period 2024-2030. Proton Therapy, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$2.3 Billion by the end of the analysis ... Read More
-
Sarcoma Drugs
... CAGR of 7.6% over the analysis period 2024-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$1.9 Billion by the end of the analysis ... Read More
-
Tabletop Kitchen Products
... at a CAGR of 4.1% over the analysis period 2024-2030. Dinnerware, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$22.9 Billion by the end of the ... Read More
-
Multiple Sclerosis Drugs
... at a CAGR of 6.7% over the analysis period 2024-2030. Immmunomoderator Drugs, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$13.2 Billion by the end of ... Read More
-
Prostate Cancer Diagnostics
... at a CAGR of 13.3% over the analysis period 2024-2030. Preliminary, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$10.0 Billion by the end of the ... Read More
-
Radiodermatitis
... 4.2% over the analysis period 2024-2030. Topical, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$412.0 Million by the end of the analysis period. Growth in ... Read More
-
Colorectal Cancer Therapeutics
... at a CAGR of 6.5% over the analysis period 2024-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$14.9 Billion by the end of ... Read More
-
Antimicrobial Coatings
... CAGR of 8.1% over the analysis period 2024-2030. Silver, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$8.3 Billion by the end of the analysis period. ... Read More
-
Sleep Apnea Diagnostic and Therapeutic Devices
... reach US$14.0 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. Diagnostic Devices, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach ... Read More
-
Blood Pressure Monitoring and Measurement Instruments
... reach US$4.3 Billion by 2030, growing at a CAGR of 9.4% over the analysis period 2024-2030. Sphygmomanometers, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$1.4 ... Read More
-
Bariatric (Obesity) Surgical Devices
... 2030, growing at a CAGR of 8.4% over the analysis period 2024-2030. Sleeve Gastrectomy, one of the segments analyzed in the report, is expected to record a 11.4% CAGR and reach US$3.6 Billion by the ... Read More
-
Connectors
... 5.8% over the analysis period 2024-2030. PCB Connectors, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$34.0 Billion by the end of the analysis period. Growth ... Read More
-
Anemia Drugs
... CAGR of 4.1% over the analysis period 2024-2030. Iron Deficiency Anemia, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$7.4 Billion by the end of the ... Read More
Research Assistance
